Barbara Tate

Chief Strategy Officer

Barbara joined DDF as a Venture Partner in 2016 and became Chief Strategy Officer in 2018.

Prior Experience
Barbara is a neuroscientist who has worked in both large and small pharmaceutical companies. She was Vice President and Head of Biology at Rodin Therapeutics, an Atlas Venture company, where she also consulted on other portfolio companies. Prior to Rodin, Barbara was Vice President for Research at Satori Pharmaceuticals, a biotech company developing a treatment for Alzheimer’s disease. At Pfizer, Barbara managed the neurodegenerative disease area group in Groton, CT. Prior to working in industry, Barbara was an academic researcher at Brown Medical School and Harvard Medical School.


Academic Credentials
BA in Biology, a PhD in Physiology, and was a postdoctoral fellow at Harvard Medical School.

Outside of SV
Barbara enjoys long distance running with family and friends, as well as her horses and dog on her farm in CT.

Dementia Discovery Fund